Incorporation of Biologic Response Variance Modeling Into the Clinic: Limiting Risk of Brachial Plexopathy and Other Late Effects of Breast Cancer Proton Beam Therapy

PURPOSE: The relative biologic effectiveness (RBE) rises with increasing linear energy transfer toward the end of proton tracks. Presently, there is no consensus on how RBE heterogeneity should be accounted for in breast cancer proton therapy treatment planning. Our purpose was to determine the dosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutter, Robert W., Jethwa, Krishan R., Tseung, Hok Seum Wan Chan, Wick, Stephanie M., Kahila, Mohamed M.H., Viehman, Jason K., Shumway, Dean A., Corbin, Kimberly S., Park, Sean S., Remmes, Nicholas B., Whitaker, Thomas J., Beltran, Chris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734652/
https://www.ncbi.nlm.nih.gov/pubmed/31494289
http://dx.doi.org/10.1016/j.prro.2019.08.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734652/
https://www.ncbi.nlm.nih.gov/pubmed/31494289
http://dx.doi.org/10.1016/j.prro.2019.08.011

Ejemplares similares